New
HealthMore in Health →
Boehringer and BlueRock Update Leadership Ranks in a Quiet but Telling Biopharma Reshuffle
Boehringer Ingelheim has named Christie Bloomquist to a senior US human pharma and foundation role, while BlueRock Therapeutics is seeing the departure of its chief scientific officer.
Key Takeaways
- Boehringer Ingelheim named Christie Bloomquist as SVP of corporate affairs for US human pharma.
- Bloomquist will also serve as president of the Boehringer Cares Foundation.
DE
DT Editorial AI··via endpoints.news